Iron and erythropoietin to heal and recover after intensive care (ITHRIVE): A pilot randomised clinical trial

CONCLUSION: The iron and erythropoietin to heal and recover after intensive care (ITHRIVE) pilot demonstrated feasibility based on predefined participant recruitment, study drug administration, and follow-up thresholds.PMID:38236513 | PMC:PMC10790015 | DOI:10.1016/j.ccrj.2023.10.007
Source: Critical Care and Resuscitation - Category: Intensive Care Authors: Source Type: research